Share

October 09, 2012; 79 (15) Articles

Serum lycopene decreases the risk of stroke in men

A population-based follow-up study

Jouni Karppi, Jari A. Laukkanen, Juhani Sivenius, Kimmo Ronkainen, Sudhir Kurl
First published October 8, 2012, DOI: https://doi.org/10.1212/WNL.0b013e31826e26a6
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
359

Share

Article Information

vol. 79 no. 15 1540-1547
DOI: 
https://doi.org/10.1212/WNL.0b013e31826e26a6
PubMed: 
23045517
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received March 5, 2012
  • Accepted June 6, 2012
  • First Published October 8, 2012.
Copyright & Usage: 
Copyright © 2012 by AAN Enterprises, Inc.

Author Disclosures

    1. Jouni Karppi, PhD,
    2. Jari A. Laukkanen, MD, PhD,
    3. Juhani Sivenius, MD, PhD,
    4. Kimmo Ronkainen, MSc and
    5. Sudhir Kurl, MD
  1. Jouni Karppi, PhD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. EVO funding of Lapland Central Hospital.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jari A. Laukkanen, MD, PhD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Juhani Sivenius, MD, PhD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Kimmo Ronkainen, MSc and
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Sudhir Kurl, MD
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers’ Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Medicine, Institute of Public Health and Clinical Nutrition (J.K., J.A.L., K.R., S.K.), University of Eastern Finland, Kuopio; Department of Internal Medicine (J.A.L.), Lapland Central Hospital, Rovaniemi; and Department of Neurology (J.S.), University Hospital of Kuopio and Brain Research and Rehabilitation Centre Neuron, Kuopio, Finland.
  1. Correspondence & reprint requests to Dr. Karppi: jouni.karppi{at}uef.fi
View Full Text

Article usage

Article usage: October 2012 to April 2019

AbstractFullPdfSource
Oct 2012836380180Highwire
Nov 201212562040Highwire
Dec 2012635710Highwire
Jan 2013996311Highwire
Feb 201357216Highwire
Mar 201345735Highwire
Apr 2013659712Highwire
May 201341401Highwire
Jun 201328313Highwire
Jul 201336400Highwire
Aug 201326416Highwire
Sep 201335235Highwire
Oct 201338754Highwire
Nov 201334025Highwire
Dec 201332721Highwire
Jan 201433932Highwire
Feb 201433243Highwire
Mar 201434223Highwire
Apr 201422813Highwire
May 201421163Highwire
Jun 201439644Highwire
Jul 201432701Highwire
Aug 201419110Highwire
Sep 201417900Highwire
Oct 201425310Highwire
Nov 201419521Highwire
Dec 201423700Highwire
Jan 201528035Highwire
Feb 201541300Highwire
Mar 201526563Highwire
Apr 201520900Highwire
May 201518201Highwire
Jun 201513301Highwire
Jul 201523014Highwire
Aug 201530323Highwire
Sep 201549226Highwire
Oct 201519110Highwire
Nov 201521432Highwire
Dec 201518900Highwire
Jan 201621700Highwire
Feb 201633100Highwire
Mar 201618800Highwire
Apr 201621110Highwire
May 201627401Highwire
Jun 201631011Highwire
Jul 201628000Highwire
Aug 201631701Highwire
Sep 201649000Highwire
Oct 201622300Highwire
Nov 201620500Highwire
Dec 201623100Highwire
Jan 201727700Highwire
Feb 201716700Highwire
Mar 201719100Highwire
Apr 201718100Highwire
May 201724200Highwire
Jun 201720512Highwire
Jul 201717500Highwire
Aug 201723700Highwire
Sep 201718200Highwire
Oct 201718801Highwire
Nov 201722801Highwire
Dec 201716901Highwire
Jan 201816021Highwire
Feb 201818593Highwire
Mar 201824243Highwire
Apr 2018259194Highwire
May 201835200Highwire
Jun 201832200Highwire
Jul 201816821Highwire
Aug 201819610Highwire
Sep 201819922Highwire
Oct 201818811Highwire
Nov 201822810Highwire
Dec 2018149712Highwire
Jan 201927100Highwire
Feb 201942400Highwire
Mar 201918600Highwire
Apr 201920810Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me